Literature DB >> 24561200

Deregulation of cell signaling in cancer.

Filippo G Giancotti1.   

Abstract

Oncogenic mutations disrupt the regulatory circuits that govern cell function, enabling tumor cells to undergo de-regulated mitogenesis, to resist to pro-apoptotic insults, and to invade through tissue boundaries. Cancer cell biology has played a crucial role in elucidating the signaling mechanisms by which oncogenic mutations sustain these malignant behaviors and thereby in identifying rational targets for cancer drugs. The efficacy of such targeted therapies illustrate the power of a reductionist approach to the study of cancer.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer cell biology; Cell signaling; Targeted therapies; Tumorigenesis

Mesh:

Year:  2014        PMID: 24561200      PMCID: PMC4111980          DOI: 10.1016/j.febslet.2014.02.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  139 in total

Review 1.  Cell migration: integrating signals from front to back.

Authors:  Anne J Ridley; Martin A Schwartz; Keith Burridge; Richard A Firtel; Mark H Ginsberg; Gary Borisy; J Thomas Parsons; Alan Rick Horwitz
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

Review 2.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Recycling the cell cycle: cyclins revisited.

Authors:  Andrew W Murray
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 4.  Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems.

Authors:  Tony Pawson
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 5.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 6.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer.

Authors:  Ugo Cavallaro; Gerhard Christofori
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 7.  Stem cells and cancer; the polycomb connection.

Authors:  Merel E Valk-Lingbeek; Sophia W M Bruggeman; Maarten van Lohuizen
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

Review 8.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 9.  Cytochrome C-mediated apoptosis.

Authors:  Xuejun Jiang; Xiaodong Wang
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 10.  Principles of tumor suppression.

Authors:  Charles J Sherr
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

View more
  40 in total

1.  Ca2+ signaling as a mechanism of haloperidol-induced cytotoxicity in human astrocytes and assessing the protective role of a Ca2+ chelator.

Authors:  Shu-Shong Hsu; Wei-Zhe Liang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-27       Impact factor: 3.000

2.  Cumulative mechanism of several major imatinib-resistant mutations in Abl kinase.

Authors:  Marc Hoemberger; Warintra Pitsawong; Dorothee Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

3.  MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes.

Authors:  Farahnaz Moghadamnia; Pegah Ghoraeian; Sara Minaeian; Atefeh Talebi; Farnaz Farsi; Abolfazl Akbari
Journal:  J Gastrointest Cancer       Date:  2020-03

4.  Physical biology of the cancer cell glycocalyx.

Authors:  Joe Chin-Hun Kuo; Jay G Gandhi; Roseanna N Zia; Matthew J Paszek
Journal:  Nat Phys       Date:  2018-07-04       Impact factor: 20.034

5.  An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation.

Authors:  Osama A Arshad; Vincent Danna; Vladislav A Petyuk; Paul D Piehowski; Tao Liu; Karin D Rodland; Jason E McDermott
Journal:  Mol Cell Proteomics       Date:  2019-06-21       Impact factor: 5.911

6.  Cancer: a new role for non-canonical Hippo signaling.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  Cell Res       Date:  2017-02-28       Impact factor: 25.617

Review 7.  Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.

Authors:  Yves Mugabo; Gareth E Lim
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

8.  High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions.

Authors:  Marsilius Mues; Laila Karra; Damia Romero-Moya; Anica Wandler; Matthew J Hangauer; Olga Ksionda; Yvonne Thus; Marthe Lindenbergh; Kevin Shannon; Michael T McManus; Jeroen P Roose
Journal:  Cell Rep       Date:  2019-04-09       Impact factor: 9.423

Review 9.  Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.

Authors:  Somayeh Vandghanooni; Morteza Eskandani; Jaleh Barar; Yadollah Omidi
Journal:  J Mol Med (Berl)       Date:  2018-07-28       Impact factor: 4.599

Review 10.  Targeting cancer via ribosome biogenesis: the cachexia perspective.

Authors:  Vandré Casagrande Figueiredo; John J McCarthy
Journal:  Cell Mol Life Sci       Date:  2021-07-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.